Tirzepatide BAC Water & Reconstitution Calculator

Dual GIP / GLP-1U-100 Syringe Math

Determine the exact volume of bacteriostatic water to add to your Tirzepatide research vial and calculate the precise syringe units to draw for 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg protocols.

Specialized GLP-1 / GIP Dual Agonist Tool

Tirzepatide BAC Water & Dosage Calculator

Precision bacteriostatic water reconstitution math, U-100 syringe unit draw calculations, and 4-week clinical escalation planning.

Standard: 10mg / 15mg / 30mg
2.0 mL is most common
Standard Clinical Escalation Steps
Custom Dose Value
Unit
Optional Budget & Schedule Analyzer
Draw Verification ResultU-100 Scale

Pull Syringe Plunger Exactly To:

50.0Units
Liquid Volume:0.500 mL
0 Units (Needle Hub)50.0 Units Mark100u Max
Concentration
5.00 mg/mL
Vial Yield
4.0 doses
Vial Longevity
~4.0 weeks
Bacteriostatic Water Storage Rule (28 Days)Once reconstituted with Bacteriostatic Water, store Tirzepatide refrigerated between 2°C - 8°C (36°F - 46°F). Never freeze reconstituted liquid.
Dynamic Protocol Map

Tirzepatide Titration Schedule (SURMOUNT Protocol) for your 10mg / 2mL Mix

Standard clinical protocol increases dose every 4 weeks. Below is your exact syringe draw for every escalation tier based on your current dilution (5.00 mg/mL):

StageTimeframeDose (mg)Exact Units to DrawVolume (mL)Doses per 10mg VialAction
Stage 1 (Initiation)
Weeks 1 - 42.5 mg50.0 units0.500 mL4.0 doses
Stage 2 (Low Therapeutic)Weeks 5 - 85 mg100.0 units1.000 mL2.0 doses
Stage 3 (Moderate)Weeks 9 - 127.5 mg150.0 units1.500 mL1.3 doses
Stage 4 (Standard High)Weeks 13 - 1610 mg200.0 units2.000 mL1.0 doses
Stage 5 (High Dose)Weeks 17 - 2012.5 mg250.0 units2.500 mL0.8 doses
Stage 6 (Max Maintenance)Weeks 21+15 mg300.0 units3.000 mL0.7 doses

5-Step Bacteriostatic Water Reconstitution Protocol

1. Sterilize TopsSwab rubber stoppers of both the Tirzepatide vial and BAC water vial with a fresh 70% isopropyl alcohol wipe. Allow to air dry for 10 seconds.
2. Draw BAC WaterDraw exactly 2 mL of sterile bacteriostatic water using a reconstitution syringe (or 1mL insulin syringe in split draws).
3. Angled InjectionInsert needle at a 45-degree angle into the Tirzepatide vial stopper. Let the water trickle slowly down the inside glass wall. Never spray directly onto powder.
4. Gentle Roll (No Shaking)Gently swirl or roll the vial between your palms until the lyophilized cake is fully dissolved and crystal clear. Never shake vigorously.
5. Refrigerate ImmediatelyStore the reconstituted Tirzepatide solution in a refrigerator at 2°C - 8°C (36°F - 46°F). Protected from direct light, solution remains stable for 28 days.

Tirzepatide Reconstitution Cheat Sheet & Quick-Reference Table

*Requires 2 draws or >100u syringe

Find your vial size and added bacteriostatic water volume in the left columns to cross-reference the exact U-100 syringe units for every standard research dose:

Vial SizeBAC WaterConcentration2.5 mg Dose5.0 mg Dose7.5 mg Dose10.0 mg Dose15.0 mg Dose
5 mg1.0 mL5.0 mg/mL50 units100 units - - -
5 mg2.0 mL2.5 mg/mL100 units - - - -
10 mg1.0 mL10.0 mg/mL25 units50 units75 units100 units -
10 mg2.0 mL5.0 mg/mL50 units100 units - - -
15 mg1.5 mL10.0 mg/mL25 units50 units75 units100 units150 units*
15 mg3.0 mL5.0 mg/mL50 units100 units150 units* - -
20 mg2.0 mL10.0 mg/mL25 units50 units75 units100 units150 units*
30 mg3.0 mL10.0 mg/mL25 units50 units75 units100 units150 units*
60 mg3.0 mL20.0 mg/mL12.5 units25 units37.5 units50 units75 units
OE
Written by OnePeptideShip Editorial Team
Reviewed by Dr. Aris Thorne, MD, Board Certified Endocrinology Advisor
Updated September 2026

How Tirzepatide Reconstitution Math Works

Tirzepatide is supplied in lyophilized (freeze-dried) powder form inside a sterile glass vial to guarantee chemical stability. Before it can be administered via subcutaneous injection, it must be reconstituted with sterile bacteriostatic water.

The arithmetic behind peptide reconstitution relies on two primary equations:

1. Concentration Formula
Concentration (mg/mL) = Total Vial mg ÷ Added BAC Water mL
Example: 10 mg ÷ 2.0 mL = 5.0 mg/mL
2. Syringe Units Formula
Units to Draw = (Target Dose mg ÷ Concentration) × 100
Example: (2.5 mg ÷ 5.0 mg/mL) × 100 = 50 Units (0.50 mL)

Dual GIP & GLP-1 Pharmacology: Why Tirzepatide Outperforms Single Agonists

Unlike first-generation weight-loss peptides like Semaglutide (which solely target the GLP-1 receptor), Tirzepatide is a synthetic 39-amino-acid peptide engineered as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist.

  • GLP-1 Receptor Activation: Acts centrally on the hypothalamus to silence appetite ("food noise"), slows gastric motility, and stimulates glucose-dependent insulin release from pancreatic beta cells.
  • GIP Receptor Synergism: Enhances insulin sensitivity in subcutaneous adipose tissue, stimulates lipolysis, improves lipid buffering, and moderates the central nausea pathways typically induced by pure GLP-1 stimulation.

Critical Reconstitution Rules: Protecting Peptide Molecular Integrity

Laboratory Best Practices:

  • Never shake the vial: Peptides possess delicate tertiary protein structures. Shaking introduces shear stress that can denature and inactivate the molecules. Always swirl gently.
  • Trickle down the glass wall: Direct the stream of bacteriostatic water against the inner glass wall so the liquid rolls down into the powder slowly.
  • Equalize pressure: If you feel negative pressure (vacuum) resisting your syringe plunger, allow air to equalize gently before withdrawing the reconstitution needle.
  • Refrigeration: Keep reconstituted solution between 2°C - 8°C (36°F - 46°F). Never freeze reconstituted liquid.
Research & Educational Mathematical Tool Notice:This calculator provides deterministic arithmetic volume conversions based on user-entered values. It does not prescribe medical treatments, diagnose conditions, or formulate individualized pharmaceutical plans. Tirzepatide research protocols must be supervised by qualified laboratory or clinical investigators.

Frequently Asked Questions

Adding 2.0 mL of Bacteriostatic Water to a 10mg vial is the most widely recommended protocol. This creates an even concentration of 5.0 mg/mL (50 mcg per unit). For the standard 2.5mg initiation dose, you pull the U-100 syringe plunger to exactly 50 units (0.50 mL). For a 5.0mg dose, you pull to 100 units (1.0 mL).

For a 15mg vial, adding 3.0 mL creates a 5.0 mg/mL solution (2.5mg = 50 units, 5.0mg = 100 units, 7.5mg = 150 units across two syringes). Alternatively, adding 1.5 mL creates a denser 10.0 mg/mL solution (2.5mg = 25 units, 5.0mg = 50 units, 7.5mg = 75 units). For a 30mg vial, adding 3.0 mL yields a convenient 10.0 mg/mL concentration.

Bacteriostatic Water (BAC water) contains 0.9% benzyl alcohol, which acts as a bacteriostatic preservative preventing bacterial replication each time a multi-dose rubber stopper is punctured. Plain sterile water has no preservative; once punctured, bacteria will multiply within 24 to 48 hours, rendering the peptide unsafe and degraded.

Syringe units depend strictly on your vial size and liquid dilution. In a 10mg vial with 2mL BAC water: 2.5mg = 50 units. In a 10mg vial with 1mL BAC water: 2.5mg = 25 units. In a 15mg vial with 3mL BAC water: 2.5mg = 50 units. In a 30mg vial with 3mL BAC water: 2.5mg = 25 units. Use our calculator widget above to calculate your exact parameters.

Clinical trials (SURMOUNT and SURPASS protocols) mandate a 4-week step-wise escalation: Weeks 1-4: 2.5mg/week (initiation) → Weeks 5-8: 5.0mg/week → Weeks 9-12: 7.5mg/week → Weeks 13-16: 10.0mg/week → Weeks 17-20: 12.5mg/week → Weeks 21+: 15.0mg/week (maximum maintenance). Skipping steps is strongly discouraged due to acute gastrointestinal distress and vomiting.

When reconstituted with genuine Bacteriostatic Water and stored in a sealed sterile vial between 2°C and 8°C (36°F - 46°F), Tirzepatide maintains chemical potency for up to 28 days. Protect the vial from direct UV light and never freeze liquid peptide after reconstitution.

Many researchers and clinicians explore splitting the weekly dose (e.g. injecting half the weekly dose every 3.5 days, such as Monday morning and Thursday evening). Because Tirzepatide has a 5-day half-life, split dosing can smooth out peak plasma concentration spikes, potentially reducing nausea while eliminating end-of-week appetite rebound.

Related GLP-1 & Peptide Calculators

View All Tools